Press "Enter" to skip to content

AACR: Apexigen, BMS steal the show with promising I-O combo in pancreatic cancer – FierceBiotech

admin 0

AACR: Apexigen, BMS steal the show with promising I-O combo in pancreatic cancer  FierceBiotech

California biotech Apexigen said during the annual American Association for Cancer Research meeting that a combination of its CD40-activating antibody with …

“pancreatic cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *